A member company of the Ratiopharm Group, Merckle Biotec’s business segment is the manufacture of biotechnologically derived substances and of drugs made from these.
The challenge: fewer interfaces
Merckle Biotec aimed to replace an existing line to stay abreast of the increased demands for capacity and flexibility in the production of prefilled syringes. The challenge lay in keeping the cost of interface clarifications as low as possible despite the size and complexity of the project. The crucial factors for placing the order with Bosch were the convincing product portfolio covering all the processing stages and an isolator solution, which, in effect, is already adapted to the filling and sealing machine...
(PDF, 245KB)
For more information please contact:
Klaus Ullherr
Phone: +49 7951 402 517
klaus.ullherr@boschpackaging.com